Geron Faces Investor Suit After FDA Halts Clinical Trial

Geron Corp. was hit with a shareholder class action Friday in California federal court accusing the drugmaker of improperly touting the prospects of its sole drug candidate before the U.S. Food and Drug Administration put a hold on the drug's clinical more

  • Tags: